Table 3 Clinical factors for TB infection among HIV positive adults at east and west Gojjam, northwest, Ethiopia, 2017
Variables | Cases n (%) N = 139 | Controls n (%) N = 413 |
|---|---|---|
CD4 count | ||
 ≤ 200cells/μl | 62(44.6) | 64(15.5) |
 201-49cells/μl | 62(44.6) | 163(39.5) |
 ≥ 500 cells/μl | 15(10.8) | 186(45) |
Hemoglobin | ||
 < 10 mg/dl | 70(50.4) | 80(19.4) |
 10–11.99 mg/dl | 40(28.8) | 99(24) |
 ≥12 mg/dl | 29(20.8) | 234(56.6) |
BMI | ||
 < 18.5 m2/kg | 103(74) | 125(30.3) |
 ≥18.5 m2/kg | 36(26) | 288(69.7) |
Functional Status | ||
 Bedridden | 71(51.1) | 36(8.7) |
 Ambulatory | 33(23.7) | 92(22.3) |
 Working | 35(25.2) | 285(69) |
CPT prophlaxysis | ||
 Yes | 82(60) | 328(79.4) |
 No | 57((40) | 85(20.6) |
IPT prophylaxis | ||
 Yes | 42(30.2) | 148(35.8) |
 No | 97(69.8) | 265(64.2) |
WHO Staging | ||
 Stage I/II | 38(27.3) | 273(66.1) |
 Stage III/IV | 101(72.7) | 140(33.9) |